Medication Therapy Management in Community Practice
How structured MTM visits improve outcomes and expand the pharmacist's clinical role.
By Dr. Amina Rahman, PharmD5 min read
Reviewed by Dr. Khalid Mehmood, MD ·
Medication therapy management (MTM) is a structured clinical service, not a hurried counseling window at the till. In community practice it gives pharmacists a defined visit: collect a complete medication history, identify drug-related problems, agree an action plan with the patient, and document follow-up. Done well, MTM reduces duplication, closes adherence gaps, and flags safety issues that a claim adjudication screen will never see.
What a complete MTM visit includes
Start with indication, dose, and how the patient actually takes each item — prescription, OTC, supplement, and shared family medicines. Ask about swallowing difficulty, cost-related rationing, and devices (inhalers, insulin pens). Then map problems using a consistent taxonomy: untreated indication, ineffective therapy, dose too high or low, adverse effect, and non-adherence. Prioritize by harm, not by how easy the fix is.
The visit should produce a personal medication record and a medication-related action plan the patient can read. Copy relevant recommendations to the prescriber with a clear ask (stop, switch, monitor, or lab). Vague “please review” notes rarely change therapy.
High-yield targets in the community
- Beers Criteria or STOPP/START issues in older adults, especially anticholinergics and duplicate CNS depressants.
- Insulin, anticoagulants, and opioids — high-alert classes that need device technique and monitoring plans.
- Heart failure and diabetes regimens where ACE inhibitor, beta-blocker, statin, or SGLT2 inhibitor gaps are common.
- Inhaler technique and spacer use; poor technique looks like “treatment failure.”
- Renal dosing when eGFR has declined since the last fill.
Workflow that survives a busy pharmacy
Block appointment slots, even if short. Use technicians to gather refill history and vitals so the pharmacist’s time is clinical. Document in a system that can generate the required MTM elements for payers. Follow up at a defined interval — two weeks for a new insulin start, longer for a statin intolerance plan. Measure something local: 30-day readmissions you hear about, A1C follow-through, or inhaler pick-up after education.
MTM succeeds when it is treated as care, not as a billing code. Patients remember the pharmacist who explained why one tablet could stop, and prescribers remember the note that included labs, timing, and a single recommended change.
